retatrutide triple agonist glp-1 gip glucagon ly3437943 π§¬Retatrutide (LY3437943) β The Triple-Agonist Powerhouse activates GLP-1, GIP, and receptors simultaneously, setting it apart from single or dual-action drugs like semaglutide and tirzepatide. π Clinical Data β All Phases Triple Agonism Based Therapies for
Pay in 4 interest-free payments of $6.59 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Oct 13 - Oct 18




























